Author
Listed:
- Xiao-Feng Zheng
(Harvard Medical School)
- Aniruddha Sarkar
(Harvard Medical School)
- Humphrey Lotana
(Purdue University)
- Aleem Syed
(Harvard Medical School)
- Huy Nguyen
(Harvard Medical School)
- Richard G. Ivey
(Fred Hutchinson Cancer Research Center)
- Jacob J. Kennedy
(Fred Hutchinson Cancer Research Center)
- Jeffrey R. Whiteaker
(Fred Hutchinson Cancer Research Center)
- Bartłomiej Tomasik
(Harvard Medical School
Medical University of Łódź
Faculty of Medicine)
- Kaimeng Huang
(Harvard Medical School
Broad Institute of Harvard and MIT)
- Feng Li
(Harvard Medical School)
- Alan D. D’Andrea
(Harvard Medical School
Broad Institute of Harvard and MIT)
- Amanda G. Paulovich
(Fred Hutchinson Cancer Research Center)
- Kavita Shah
(Purdue University)
- Alexander Spektor
(Harvard Medical School
Broad Institute of Harvard and MIT)
- Dipanjan Chowdhury
(Harvard Medical School
Broad Institute of Harvard and MIT
Harvard Medical School)
Abstract
CDK1 has been known to be the sole cyclin-dependent kinase (CDK) partner of cyclin B1 to drive mitotic progression1. Here we demonstrate that CDK5 is active during mitosis and is necessary for maintaining mitotic fidelity. CDK5 is an atypical CDK owing to its high expression in post-mitotic neurons and activation by non-cyclin proteins p35 and p392. Here, using independent chemical genetic approaches, we specifically abrogated CDK5 activity during mitosis, and observed mitotic defects, nuclear atypia and substantial alterations in the mitotic phosphoproteome. Notably, cyclin B1 is a mitotic co-factor of CDK5. Computational modelling, comparison with experimentally derived structures of CDK–cyclin complexes and validation with mutational analysis indicate that CDK5–cyclin B1 can form a functional complex. Disruption of the CDK5–cyclin B1 complex phenocopies CDK5 abrogation in mitosis. Together, our results demonstrate that cyclin B1 partners with both CDK5 and CDK1, and CDK5–cyclin B1 functions as a canonical CDK–cyclin complex to ensure mitotic fidelity.
Suggested Citation
Xiao-Feng Zheng & Aniruddha Sarkar & Humphrey Lotana & Aleem Syed & Huy Nguyen & Richard G. Ivey & Jacob J. Kennedy & Jeffrey R. Whiteaker & Bartłomiej Tomasik & Kaimeng Huang & Feng Li & Alan D. D’An, 2024.
"CDK5–cyclin B1 regulates mitotic fidelity,"
Nature, Nature, vol. 633(8031), pages 932-940, September.
Handle:
RePEc:nat:nature:v:633:y:2024:i:8031:d:10.1038_s41586-024-07888-x
DOI: 10.1038/s41586-024-07888-x
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:633:y:2024:i:8031:d:10.1038_s41586-024-07888-x. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.